Pure Global AI
Présidence Arrêté

Arrêté n° 2023-171/PR/MS

Adoption de la Liste Nationale des Médicaments Essentiels
DjiboutiPrésidence de la République de DjiboutiGeneralCurrentness under review
Document status

Currentness under review. Whether this instrument remains applicable is under review. Consult the later instruments and source context below before relying on it.

What this code is

Arrêté n° 2023-171/PR/MS is the official Présidence identifier for “Adoption de la Liste Nationale des Médicaments Essentiels”. Arrêté n° 2023-171/PR/MS is the official identifier Présidence uses for this instrument.

Instrument
Arrêté
Full name
Arrêté n° 2023-171/PR/MS
Category
General
Source links
Source publication
French
Linked source text; confirm the publisher, publication details and any later amendment or consolidated version.
Readable HTML
1 language version
Direct citations can link to a specific article or section by appending its fragment identifier.
Dates
Published
—
Effective
—
Readable full text

Open a language version

Each version has stable passage anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.

About this regulation

Adoption de la Liste Nationale des Médicaments Essentiels

Complete two-page signed government order, hosted in the WHO official repository, with Articles 1–7 and a visible 5 December 2023 date stamp. It revises the national medicines and materials list; Article 4 includes medicines and essential materials and consumables. Article 6 repeals earlier contrary provisions, rather than stating an unconditional repeal of every earlier list rule. The complete 38-page annex is available as a separate linked corpus expression with visually reviewed table text and original-page figures. This order expression retains only its two signed adopting pages. Later amendments and current applicability remain under review.

Arrêté n° 2023-171/PR/MS is the official identifier Présidence uses for this instrument. Always confirm the current consolidated text and transition provisions with the official source before filing.